AF	atrial fibrillation
ANOVA	analysis of variance
BMI	body mass index
CAC	carnitine/acylcarnitine carrier protein
CHA2DS2-VASc	congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or TIA or thromboembolism, vascular disease, age 65–74 years, sex category (i.e., female sex)
CPT	carnitine palmitoytransferase
CRP	C reactive protein
CT	computed tomography
EDTA	ethylenediaminetetra-acetic acid
ESI–LC–MS/MS	electrospray ionization–liquid chromatography– mass spectrometry
FDR	false discovery rate
HAS-BLED	hypertension, abnormal renal or liver function, prior stroke, prior major bleeding or predisposition to bleeding, labile INR, elderly, i.e., age > 65 years, prior alcohol, drug, or medication usage predisposing to bleeding
HCA	hierarchical cluster analysis
INR	International Normalized Ratio
LAA	left atrial appendage
LAAC	left atrial appendage
LABEL	Left Atrial Appendage Occlusion and Biomarker Evaluation
LC	long chain
LDH	lactate dehydrogenase
LOD	limit of detection
LV	left ventricular
LVEF	left ventricular ejection fraction
MC	medium chain
MC	medium chain
MDRD	Modification of Diet in Renal Disease
NT-proBNP	amino-terminal pro-brain natriuretic peptide
OAC	oral anticoagulation
PCA	principal component analysis
PLS-DA	partial least squares discrimination analysis
SC	short chain
TCA	tricarboxylic acid